Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Journal of Rheumatology|April 1, 1994
Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinomaD W Puett, H A FuchsAnnals of Internal Medicine|July 15, 1994
Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritisD W Puett, M R GriffinCirculation|March 1, 1990
Mechanisms and therapy of myocardial reperfusion injuryM B Forman, R Virmani, D W PuettJournal of the American College of Cardiology|February 1, 1989
Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implicationsM B Forman, D W Puett, R VirmaniActa Endocrinologica|October 1, 1989
Extragonadal effects of luteinizing hormone in miceK Nomura, D W Puett, D Puett, et al.Journal of the American College of Cardiology|May 1, 1987
Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion modelM B Forman, D W Puett, B H Wilson, et al.Circulation|November 1, 1987
Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenonB Olafsson, M B Forman, D W Puett, et al.Circulation|July 1, 1988
Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular functionM B Forman, D W Puett, C U Cates, et al.Circulation|September 1, 1987
Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusionD W Puett, M B Forman, C U Cates, et al.Circulation|August 1, 1987
Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusionM B Forman, D W Puett, S E Bingham, et al.Pageof 1